variable

Treatment modality

RFS

p

DFS

p

OS

p

Stage III-IVa

radiotherapy

66%

0.15

44%

0.04

56%

0.004

Conc-chemoradiotherapy

71%

58%

67%

Positive margin

radiotherapy

72%

0.79

63%

0.034

60%

0.011

Conc-chemoradiotherapy

80%

75%

74%

Perineural invasion

radiotherapy

84%

0.108

58%

0.02

33%

0.03

Conc-chemoradiotherapy

85%

83%

61%